Clinical Trials Logo

Neointima clinical trials

View clinical trials related to Neointima.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05544864 Recruiting - Clinical trials for Coronary Artery Disease

Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

ISAR-DESIRE5
Start date: September 28, 2022
Phase: N/A
Study type: Interventional

The hypothesis of the study is, that there is a significant interaction in treatment effect between the OCT pattern of neointima (heterogeneous or homogeneous) and the type of percutaneous coronary intervention (drug-eluting stent or drug-coated balloon) in patients with in-stent restenosis.

NCT ID: NCT05451368 Recruiting - Clinical trials for Coronary Artery Calcification

Neointimal Features in Patients With Restenosis of Calcified Lesions

Start date: March 17, 2022
Phase:
Study type: Observational

Previous studies have suggested that restenosis (RS) after stenting is mainly due to smooth muscle cell proliferation and migration, but recent evidence suggests that in-stent restenosis(ISR) is associated with a number of factors. Coronary artery calcification is an independent predictor of ischaemia-mediated revascularisation 1 year after percutaneous coronary intervention (PCI) following RS.The characteristics of new neointima in patients with in-stent restenosis of calcified lesions are important issues to explore

NCT ID: NCT02328521 Recruiting - Diabetes Mellitus Clinical Trials

Efficacy Study of Nicorandil on Neointima

Start date: December 2014
Phase: Phase 4
Study type: Interventional

The investigators aim to investigate the effect of oral nicorandil on neointima after coronary drug-eluting stent implantation in patients with diabetic mellitus.